VINEETLABPharmaceuticals
Vineet Laboratories Ltd — PE Ratio & Valuation Analysis
₹29.06
+0.00%
Current P/EN/AxPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E40.7x100.0% below avg
✅
100.0% Discount to Industry
VINEETLAB P/E N/Ax vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹1.11 | ₹59 | 53.3x |
| 2023 | ₹1.36 | ₹82 | 60x |
| 2022 | ₹7.16 | ₹63 | 8.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Vineet Laboratories Ltd Valuation
Vineet Laboratories Ltd (VINEETLAB) currently trades at N/Ax earnings. The Pharmaceuticals sector average PE is 31.77x. Historically, VINEETLAB has traded at an average PE of 40.7x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
-89.47%
Dividend Yield
0.00%
More on Vineet Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.